News and Announcements
Browse the articles below to learn more about our faculty’s latest achievements, awards and honors.
05.16.2022A new study has identified a drug that inhibits growth of aggressive meningiomas and how to most accurately identify which tumors will respond to the drug.
05.02.2022Breaking Down a Groundbreaking Diagnostic Tool. more
05.01.2022Northwestern Medicine's Liza Cohen, MD, Oculoplastic Surgery, and Stephen Magill, MD, PhD, Neurological Surgery, discuss the case of a young woman who developed pulsatile proptosis after trauma in childhood. Imaging identified a connection between the brain and the orbit: Brain tissue was pushing into the orbit with every heartbeat, causing significant headaches and "bouncing" vision for the patient. more
04.14.2022A team led by Northwestern Medicine investigators has discovered differences in the distribution and interaction of T-cells within different parts of brain tumor and brain metastasis microenvironments.
04.05.2022Man's best friend is helping scientists find new treatments for brain tumors. Amy Heimberger, MD, is a board-certified neurosurgeon with extensive training and experience in the field of immunology. She is part of a promising new study in canine glioblastoma that could lead to more effective human glioblastoma clinical trials. more
12.21.2021Reaching the end of this pandemic year with yet another new COVID-19 variant in the mix may have many sighing and shaking their heads out of frustration and exhaustion. But if the past two years have taught us anything, it’s perseverance.
Perseverance is something Northwestern University neurosurgery resident Dr. Aaron Palmer knows something about. His career in medicine exemplifies this quality. It was shadowing a Black surgeon in his hometown of Akron, Ohio, while he was an undergrad, that put Palmer on the path to medicine. That and his father’s illness: esophageal cancer. more
12.16.2021To systematically review characteristics of DL studies involving neurosurgical outcome prediction and to assess their bias and reporting quality. more
12.16.2021The Medical Director of Neuropathology at Northwestern University, Dr. Craig Horbinski, joins Steve Bertrand on Chicago’s Afternoon News to talk about a new genetic test for brain tumors and how it improves diagnostic accuracy and treatment plans. more
12.02.2021As a neurosurgeon regularly treating glioblastomas, Dr. Adam Sonabend followed with interest the rise of immunotherapy, a new way to help cancer patients utilize the power of their own immune systems. more- 12.01.2021Dr. Heimberger, who came to Northwestern from the University of Texas MD Anderson Cancer Center in Houston earlier this year, is especially interested in cancers that don’t always attract the attention and funding of more common types of cancer. She says that when added together rare cancers actually beat the more common cancers in terms of frequency and the number of people afflicted. more on p32
11.24.2021Scientists have discovered a potential biomarker that could more accurately identify which patients with non-hypermutated cancers will respond to specialized immunotherapy drugs.
- 11.21.2021New biomarker discovery could prolong lives of estimated 20% to 30% of these malignant brain tumor patients. more
10.18.2021"If a chordoma is removed with even a single cell left behind, the chance of recurrence is exceptionally high. Ultimately, this means if you can remove the tumor in one piece, without spilling tumor cells, the less likely the cancer will come back, and the best chance you have for long-term survival."
10.07.2021The clinic, led by Dr. Drew Spencer, will provide comprehensive neurological care for a wide range of conditions. more
10.07.2021The clinic, led by Dr. Drew Spencer, will provide comprehensive neurological care for a wide range of conditions. more
10.03.2021Glioblastoma is one of the deadliest cancers known to man. While the advent of immunotherapy and other cutting-edge treatments have prolonged life for people afflicted with other types of cancer, the prognosis for glioblastoma has remained relatively constant: just 18 months. more
10.01.2021Glioblastoma is one of the deadliest cancers known to man. While the advent of immunotherapy and other cutting-edge treatments have prolonged life for people afflicted with other types of cancer, the prognosis for glioblastoma has remained relatively constant: just 18 months. more